摘要：

本发明公开了具有HCV蛋白酶抑制活性的新型化合物以及制备所述化合物的方法. The present invention discloses novel compounds having HCV protease inhibitory activity as well as methods for preparing said compounds. 在另一实施方案中,本发明公开了包含所述化合物的药用组合物以及将其用于治疗HCV蛋白酶相关性疾病的方法. In another embodiment, the present invention discloses pharmaceutical compositions comprising said compounds as well as methods of treating an HCV protease-related diseases used.

展开